Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review
In recent years, knowledge about mechanisms underlying mast cell activation (MCA) and accumulation in various pathologic conditions increased substantially. In addition, criteria and a classification of MCA syndromes (MCASs) have been set forth. MCAS is defined by typical clinical symptoms, a substa...
| Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/268013 |
| Acceso en línea: | http://hdl.handle.net/10261/268013 |
| Access Level: | acceso abierto |
| Palabra clave: | Mast cells MCAS Tryptase Hereditary alpha Tryptasemia Mastocytosis Anaphylaxis Vienna consensus criteria |
| id |
ES_ca532b853b2cf7bb381465a5ba39bd49 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/268013 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical ReviewGülen, TheoAkin, CemBonadonna, PatriziaSiebenhaar, FrankBroesby-Olsen, SigurdBrockow, KnutNiedoszytko, MarekNedoszytko, BoguslawOude Elberink, HannekeButterfield, Joseph H.Sperr, Wolfgang R.Álvarez-Twose, IvánHorny, Hans-PeterSotlar, KarlSchwaab, JulianaJawhar, MohamadZanotti, RobertaNilsson, GunnarLyons, Jonathan J.Carter, Melody C.George, Tracy I.Hermine, OlivierGotlib, JasonOrfao, AlbertoTriggiani, MassimoReiter, AndreasHartmann, KarinCastells, MarianaArock, MichelSchwartz, Lawrence B.Metcalfe, Dean D.Valent, PeterMast cellsMCASTryptaseHereditary alpha TryptasemiaMastocytosisAnaphylaxisVienna consensus criteriaIn recent years, knowledge about mechanisms underlying mast cell activation (MCA) and accumulation in various pathologic conditions increased substantially. In addition, criteria and a classification of MCA syndromes (MCASs) have been set forth. MCAS is defined by typical clinical symptoms, a substantial increase in serum tryptase level during an attack over the patient's baseline tryptase, and a response of the symptoms to drugs targeting mast cells, mediator production, and/or mediator effects. Alternative diagnostic criteria of MCAS have also been suggested, but these alternative criteria often lack specificity and validation. In this report, we critically review the contemporary literature relating to MCAS and compare the specificity, sensitivity, and strength of MCAS-related parameters within proposals to diagnose and classify MCAS and its variants. Furthermore, we highlight the need to apply specific consensus criteria in the evaluation and classification of MCAS in individual patients. This is an urgent and important medical necessity because as an increasing number of patients are being given a misdiagnosis of MCAS based on nonspecific criteria, which contributes to confusion and frustration by patients and caregivers and sometimes may delay recognition and treatment of correct medical conditions that often turn out to be unrelated to MCA.ElsevierConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2022202220212022info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Publisher's versioninfo:eu-repo/semantics/publishedVersionhttp://hdl.handle.net/10261/268013reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://dx.doi.org/10.1016/j.jaip.2021.06.011Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/2680132026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
| title |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
| spellingShingle |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review Gülen, Theo Mast cells MCAS Tryptase Hereditary alpha Tryptasemia Mastocytosis Anaphylaxis Vienna consensus criteria |
| title_short |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
| title_full |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
| title_fullStr |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
| title_full_unstemmed |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
| title_sort |
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review |
| dc.creator.none.fl_str_mv |
Gülen, Theo Akin, Cem Bonadonna, Patrizia Siebenhaar, Frank Broesby-Olsen, Sigurd Brockow, Knut Niedoszytko, Marek Nedoszytko, Boguslaw Oude Elberink, Hanneke Butterfield, Joseph H. Sperr, Wolfgang R. Álvarez-Twose, Iván Horny, Hans-Peter Sotlar, Karl Schwaab, Juliana Jawhar, Mohamad Zanotti, Roberta Nilsson, Gunnar Lyons, Jonathan J. Carter, Melody C. George, Tracy I. Hermine, Olivier Gotlib, Jason Orfao, Alberto Triggiani, Massimo Reiter, Andreas Hartmann, Karin Castells, Mariana Arock, Michel Schwartz, Lawrence B. Metcalfe, Dean D. Valent, Peter |
| author |
Gülen, Theo |
| author_facet |
Gülen, Theo Akin, Cem Bonadonna, Patrizia Siebenhaar, Frank Broesby-Olsen, Sigurd Brockow, Knut Niedoszytko, Marek Nedoszytko, Boguslaw Oude Elberink, Hanneke Butterfield, Joseph H. Sperr, Wolfgang R. Álvarez-Twose, Iván Horny, Hans-Peter Sotlar, Karl Schwaab, Juliana Jawhar, Mohamad Zanotti, Roberta Nilsson, Gunnar Lyons, Jonathan J. Carter, Melody C. George, Tracy I. Hermine, Olivier Gotlib, Jason Orfao, Alberto Triggiani, Massimo Reiter, Andreas Hartmann, Karin Castells, Mariana Arock, Michel Schwartz, Lawrence B. Metcalfe, Dean D. Valent, Peter |
| author_role |
author |
| author2 |
Akin, Cem Bonadonna, Patrizia Siebenhaar, Frank Broesby-Olsen, Sigurd Brockow, Knut Niedoszytko, Marek Nedoszytko, Boguslaw Oude Elberink, Hanneke Butterfield, Joseph H. Sperr, Wolfgang R. Álvarez-Twose, Iván Horny, Hans-Peter Sotlar, Karl Schwaab, Juliana Jawhar, Mohamad Zanotti, Roberta Nilsson, Gunnar Lyons, Jonathan J. Carter, Melody C. George, Tracy I. Hermine, Olivier Gotlib, Jason Orfao, Alberto Triggiani, Massimo Reiter, Andreas Hartmann, Karin Castells, Mariana Arock, Michel Schwartz, Lawrence B. Metcalfe, Dean D. Valent, Peter |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
Mast cells MCAS Tryptase Hereditary alpha Tryptasemia Mastocytosis Anaphylaxis Vienna consensus criteria |
| topic |
Mast cells MCAS Tryptase Hereditary alpha Tryptasemia Mastocytosis Anaphylaxis Vienna consensus criteria |
| description |
In recent years, knowledge about mechanisms underlying mast cell activation (MCA) and accumulation in various pathologic conditions increased substantially. In addition, criteria and a classification of MCA syndromes (MCASs) have been set forth. MCAS is defined by typical clinical symptoms, a substantial increase in serum tryptase level during an attack over the patient's baseline tryptase, and a response of the symptoms to drugs targeting mast cells, mediator production, and/or mediator effects. Alternative diagnostic criteria of MCAS have also been suggested, but these alternative criteria often lack specificity and validation. In this report, we critically review the contemporary literature relating to MCAS and compare the specificity, sensitivity, and strength of MCAS-related parameters within proposals to diagnose and classify MCAS and its variants. Furthermore, we highlight the need to apply specific consensus criteria in the evaluation and classification of MCAS in individual patients. This is an urgent and important medical necessity because as an increasing number of patients are being given a misdiagnosis of MCAS based on nonspecific criteria, which contributes to confusion and frustration by patients and caregivers and sometimes may delay recognition and treatment of correct medical conditions that often turn out to be unrelated to MCA. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 2022 2022 2022 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Publisher's version info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/268013 |
| url |
http://hdl.handle.net/10261/268013 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
http://dx.doi.org/10.1016/j.jaip.2021.06.011 Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869419469971914752 |
| score |
15,812429 |